Carol Suh's most recent trade in Neumora Therapeutics Inc. was a trade of 170,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neumora Therapeutics Inc. | Carol Suh | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Suh Carol | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 85,000 | 374,674 | - | 0 | Common Stock |